{"cik":"0001885522","ticker":"NMRA","name":"Neumora Therapeutics, Inc.","sic_code":"2836","sic_description":"Biological Products, (No Diagnostic Substances)","exchange":"Nasdaq","state_of_incorporation":"DE","fiscal_year_end":"1231","first_filing_date":"2026-05-15","last_filing_date":"2026-06-15","url":"/sec/cik-0001885522","insider_summary":{"total_transactions":0,"unique_insiders":0,"latest_transaction":null},"recent_filings":[{"accession_number":"0001193125-26-270328","form_type":"8-K","form_type_family":"current","doc_date":"2026-06-15","title":"8-K — Neumora Therapeutics, Inc. — 2026-06-15","url_slug":"/sec/cik-0001885522/8-k/0001193125-26-270328","edgar_url":"https://www.sec.gov/Archives/edgar/data/1885522/0001193125-26-270328-index.html"},{"accession_number":"0000905148-26-002417","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-05-15","title":"SCHEDULE 13G/A — Neumora Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001885522/schedule-13g-a/0000905148-26-002417","edgar_url":"https://www.sec.gov/Archives/edgar/data/1885522/0000905148-26-002417-index.html"}],"related_endpoints":{"profile":"/sec/NMRA/profile","timeline":"/sec/NMRA/timeline","peers":"/sec/NMRA/peers","insider_pulse":"/sec/NMRA/insider-pulse","insider_summary":"/sec/NMRA/insider-summary","insider_transactions":"/sec/NMRA/insider-transactions","form144":"/sec/NMRA/form144","holdings_as_filer":"/sec/NMRA/holdings","financial_facts":"/sec/NMRA/financial-facts","derivatives":"/sec/NMRA/derivatives","officers":"/sec/NMRA/officers","insider_network":"/sec/NMRA/insider-network","risk_flags":"/sec/NMRA/risk-flags","filings":"/sec/NMRA/filings","cross_topic_dossier":"/api/v1/dossier?ticker=NMRA"}}